Benefits
LDL cholesterol reduction
Scope this carefully. The largest figures quoted on this page, total cholesterol down 6.74% and LDL down 12.3%, come from the Farsi 2023 crossover trial, which is not among this page's references and is therefore uncited here. What the cited evidence actually shows is a 7-day randomized trial in 20 healthy adults in which 45 plasma lipid concentrations fell by 7 to 27% (all P<0.05) when mycoprotein replaced meat and fish (32660657). That is a one-week lipidomic shift in a small group, not a demonstrated durable LDL reduction. The proposed reasons, more soluble fiber and less saturated fat than red meat, are plausible but were not tested directly.
Satiety and weight management
In a randomized controlled trial in healthy overweight and obese adults, a mycoprotein meal reduced energy intake at a later meal (27198187). The proposed reasons, high fiber content and texture, were not isolated in that trial. This is a short-term appetite finding, and no trial cited on this page measured body weight or body composition change, so nothing here shows weight loss.
Lower postprandial insulin, but no change in insulin sensitivity
Both results belong here. In overweight and obese adults, a mycoprotein meal lowered the postprandial insulin response without altering glucose (27198187). Over a longer window the result was null: in 20 healthy adults eating mycoprotein daily for 1 week there were no changes within or between groups in blood glucose, serum insulin, insulin sensitivity, or 24-hour glycemic profiles, and the paper is titled for that null finding (32660657). Nothing here supports use for any blood sugar condition.
Complete plant-based protein
Provides all essential amino acids in roughly the proportions needed for human protein synthesis. Two small randomized trials measured muscle protein synthesis rates, one in 20 resistance-trained young men (32438401) and one in 19 older adults (33172506). Both measured synthesis rates only. Neither measured strength, muscle size, endurance, or any exercise performance outcome, so nothing on this page shows improved performance. Leucine content per gram is lower than in whey or milk protein, which is why the young-men trial matched leucine by giving a larger serving of mycoprotein than of milk protein.
Environmental footprint, not a health effect
Mycoprotein production is generally reported to use less land and water and to produce fewer greenhouse gas emissions than animal protein. None of the studies cited on this page measured any environmental outcome, so this entry is uncited here. It is also an environmental consideration rather than a health benefit, and it is listed only because some buyers weigh it.
Mechanism of action
Bile acid sequestration and cholesterol reduction
Mycoprotein's fungal cell wall contains β-glucan (β-1,3/1,6, distinct from oat's β-1,3/1,4) and chitin — both viscous, fermentable fibers that bind bile acids in small intestine. Liver compensates by synthesizing more bile from cholesterol, depleting hepatic cholesterol pool. LDL receptor upregulation increases LDL clearance. Mechanism is similar to oat beta-glucan but with chitin contributing additional binding capacity.
Muscle protein synthesis via amino acid delivery
Mycoprotein provides a complete amino acid profile (PDCAAS ~0.99, comparable to milk and beef) with less leucine per gram than whey or milk protein; the trial cited here matched leucine by using a larger mycoprotein serving, 70 g supplying 31.5 g protein and 2.5 g leucine (32438401), so the practical serving is larger and there is no established 40 g protein threshold. The finding of more MPS than leucine-matched milk protein suggests possible additional effects beyond leucine, perhaps prebiotic/fiber-derived metabolites or unique fungal amino acid signaling not yet fully characterized.
Prebiotic/SCFA production from fungal fiber
Chitin and β-glucan from fungal cell walls are fermented by colonic bacteria producing short-chain fatty acids (acetate, propionate, butyrate). Shifts in Bifidobacteria and Faecalibacterium prausnitzii have been reported elsewhere, but no reference on this page measured the gut microbiome or short-chain fatty acid production. May contribute to anti-inflammatory effects, gut health, and possibly indirect metabolic benefits.
Glycemic load reduction (viscous fiber gel)
β-glucan and chitin form viscous gel in stomach/small intestine, slowing gastric emptying and glucose diffusion. This is the proposed mechanism, and it did not produce the expected results in the cited trials: the acute trial found lower insulin with no change in glucose (27198187), and the 1-week trial found no change in insulin sensitivity or 24-hour glycemia (32660657). Treat the comparison with oat beta-glucan as a hypothesis rather than a demonstrated equivalence.
Clinical trials
Randomized double-blind parallel-group trial (Monteyne AJ, Coelho MOC, Porter C, Abdelrahman DR, Jameson TSO, Jackman SR, Blackwell JR, Brook MS, Murton AJ, Alamdari N, Stephens FB, Wall BT 2020, Am J Clin Nutr 112(2):318-333, doi:10.1093/ajcn/nqaa092).
20 resistance-trained healthy young males (age 22 ± 1 y, BMI 25 ± 1) under primed continuous L-[ring-2H5]phenylalanine infusion. Ingested either 31 g milk protein (26.2 g protein, 2.5 g leucine) or 70 g mycoprotein (31.5 g protein, 2.5 g leucine — leucine-matched) following unilateral resistance exercise (contralateral leg as resting control).
Single bolus of mycoprotein stimulated resting and post-exercise muscle protein synthesis to a greater extent than leucine-matched bolus of milk protein. Statistically significant superiority of mycoprotein vs milk protein in both rested and exercised muscle. Read the limits with the result. The outcome was a muscle protein synthesis rate after a single serving, not strength, muscle size, or any exercise performance measure, so this trial says nothing about athletic performance. It ran in 20 resistance-trained young men, and the research group has links to the manufacturer. A higher synthesis rate after one serving is a short-term surrogate and does not by itself establish more muscle gained over time.
Uncited on this page: this 2019 symposium paper is not among the references listed below, so the figures summarized in this card have not been checked against a source here. A symposium paper is also a narrative review rather than a systematic review or a trial.
Review of mycoprotein clinical literature — 13 human studies investigating health properties of mycoprotein.
Documented evidence of: (1) sustained satiety (multiple acute meal trials), (2) improved metabolic profiling — 5 of 9 trials found improved blood lipid levels, with cholesterol reductions 9-13% in meaningful intervention trials, (3) muscular protein synthetic response equivalent to milk/whey, (4) glucose and insulin control benefits, (5) an assertion of low allergic reaction incidence. That last point should be read against the 2018 adverse-reaction analysis now in the references below, which describes 1,752 self-reported complaints including 312 allergic reactions and one fatal reaction. Neither source can establish an incidence rate. The review concluded that mycoprotein has nutritional and environmental advantages; its authorship overlaps with the manufacturer-linked group that produced most of the trials cited on this page.
Uncited on this page: this 2023 trial is not among the references listed below, so the percentages in this card have not been verified against a source here.
20 metabolically healthy adult males consumed 240 g/day red and processed meat for 14 days followed by mycoprotein, OR vice versa (crossover design). Blood biochemical indices were a priori secondary endpoints.
Mycoprotein consumption reduced total cholesterol by 6.74% (p=0.02) and LDL cholesterol by 12.3% (p=0.02) from baseline. Triglycerides not significantly different (+0.19 mmol/L, p=0.09). Because this trial is not among the page's references, treat these percentages as unverified here. They also come from a priori secondary endpoints in 20 metabolically healthy men over 14 days, which is a short exposure in a small and narrow group, and triglycerides did not change significantly.